December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Neil Ranasinghe: An inspiring story about a childhood survivor of bone cancer
Dec 11, 2024, 08:00

Neil Ranasinghe: An inspiring story about a childhood survivor of bone cancer

Neil Ranasinghe, Lead Technical Author at London Stock Exchange, shared a post on LinkedIn by Children’s Cancer and Leukaemia Group, adding:

“You hear the word ‘inspiring’ used a lot but this really is an inspiring story about a childhood survivor of bone cancer. Some survivors of childhood cancer see these stories and feel inadequate as they aren’t doing anything like that.

My message to all survivors of childhood cancer, try not to compare yourself with anyone. Just being you, however you are, is brilliant. You have been through so much.”

Quoting Children’s Cancer and Leukaemia Group (CCLG)’s post:

” ‘I was just 16 years old when, to save my life, I had my right leg amputated above the knee due to osteosarcoma.’

Sarah Dransfield was diagnosed with bone cancer in March 2012 aged 16.

In our latest issue of Contact magazine, she tells us what helped her during and after treatment and how cancer has changed her outlook on life.

Read the full article.”

More posts featuring Neil Ranasinghe.

Neil Ranasinghe (BA) is the parent of a childhood cancer survivor. He has volunteered his writing and leadership skills to global and UK-based cancer organizations since 2004. Neil co-founded the Pediatric Oncology Reference Team (PORT), which reviews pediatric oncology clinical trial documentation for parents and patients.

This parent-clinician collaboration improves trial design and ultimately increases clinical trial participation.

Neil is also lay representative for some clinical trials. Neil is active in the International Society of Pediatric Oncology, which advocates for children with cancer in low- or middle-income countries, and is a Global Mapping Program committee member.

Neil is a Lead Technical Author at the London Stock Exchange Group and Columnist at OncoDaily London Bureau.